Consortium of Independent Immunology Clinics, LLC
$938.8K 91 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
Carl Zeiss Meditec, Inc.
Carl Zeiss Meditec, Inc. reported $938,560.64 across General Payments, Research, and Ownership to 737 physicians and teaching hospitals across 737 transactions.
- $938.6K Above-median payer
- All-tracks total
- 737 Above-median volume
- Transactions
- 737 Above-median reach
- Recipients
- −$523.9K
- General Payments vs PY2023
Carl Zeiss Meditec, Inc. reported $938,560.64 across all CMS Open Payments tracks (General + Research + Ownership) to 737 physicians and teaching hospitals in Program Year 2024 - ranking #635 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $938,560.64, averaging $1.3K per recipient.
Carl Zeiss Meditec, Inc.'s payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
35/100
Total payments
F
19/100
Transaction volume
F
15/100
Physician reach
F
16/100
Payment type diversity
A
90/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer carl-zeiss-meditec-inc Carl Zeiss Meditec, Inc.
$938.6K · #635/1,925 · 0.0% industry · PY2024
- TOT $938.6K
- RANK #635
- SHARE 0.0%
- TXN 737
- RCP 737
- CAT 7
- GEN $938.6K
- ΔGEN −$523.9K
- TOP1 12.1%
- PY 2024
Volume peers
Nearest volume peer: Consortium of Independent Immunology Clinics, LLC ($938.8K)
Carl Zeiss Meditec, Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Carl Zeiss Meditec, Inc.'s CMS-reported General Payments decreased by $523.9K (−35.8%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: CARL ZEISS MEDITEC, INC.PY2023: CARL ZEISS MEDITEC, INC.PY2024: Carl Zeiss Meditec, Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $1,462,474.05
- PY2024
- $938,560.64
What the Data Shows for Carl Zeiss Meditec, Inc.
The all-tracks total above combines three CMS reporting categories - General Payments, Research Payments, and Ownership/Investment interests - not one undifferentiated figure. For Carl Zeiss Meditec, Inc. that figure is drawn almost entirely from the General Payments track (day-to-day consulting, meals, travel and speaking fees). CMS publishes each Program Year's data roughly 12 months after the reporting period ends, so this reflects the most recently released cycle; see our methodology for how the tracks are standardized and compared across companies.
249 transactions worth $574.3K make "Consulting Fee" the top general-payment category in the 7-category breakdown below, 61.2% of General Payments (see our methodology for how research and ownership payments are reported separately).
General Payment Breakdown by Type
"Consulting Fee" leads Carl Zeiss Meditec, Inc.'s 7-category general-payment breakdown at $574.3K, 61.2% of the reported total.
Carl Zeiss Meditec, Inc. reports 7 general-payment categories - the top three are Consulting Fee (61.2%), Grant (17.9%), and Compensation for Services Other Than Consulting (15.8%). The remaining 4 categories make up 5.2% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.
How Carl Zeiss Meditec, Inc. divides its payments
How the reported total splits across payment categories
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Consulting Fee | $574.3K | 249 | 61.2% |
| Grant | $167.9K | 17 | 17.9% |
| Compensation for Services Other Than Consulting | $147.9K | 66 | 15.8% |
| Food and Beverage | $25.4K | 381 | 2.7% |
| Travel and Lodging | $16.7K | 16 | 1.8% |
| Education | $6.3K | 5 | 0.7% |
| Gift | $48.15 | 3 | 0.0% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $340,848.53 (36.3%) of $938,560.64 in this company's General Payments records across 406 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Carl Zeiss Meditec, Inc.
The five named recipients with the highest reported General Payments from this company
- 1
Alicia Lau
$113,817.50 across 17 reported transactions
- 2
Mayo Clinic Hospital
$85,580.00 across 2 reported transactions
- 3
Jon Gordon Dishler
$60,000.00 across 1 reported transactions
- 4
Barry S Seibel
$49,051.03 across 7 reported transactions
- 5
St. Josephs Hospital & Medical Ctr
$32,400.00 across 3 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Carl Zeiss Meditec, Inc. ranks #635 of 1,925 by total payments (top 33% by spend) but spreads that money notably more broadly than its spend rank alone would suggest -- #1,392 of 1,838 by HHI (bottom 24% least concentrated), a wider distribution than most similarly sized payers.
View all 12 companies in this HHI neighborhood as a list
- Ovesco Endoscopy USA, Inc. : $61.0K total payments, HHI 384
- Augmedics Inc. : $233.7K total payments, HHI 383
- Daiichi Sankyo Inc. : $6.9M total payments, HHI 382
- Biocomposites Inc : $138.8K total payments, HHI 381
- Dental Health Products, Inc. : $7.5K total payments, HHI 380
- XVIVO Perfusion Inc. : $51.8K total payments, HHI 377
- Carl Zeiss Meditec, Inc. (this company) : $938.6K total payments, HHI 376
- CDC Medical LLC : $22.6K total payments, HHI 376
- Gynesonics, Inc. : $1.1M total payments, HHI 375
- BioCryst US Sales Co., LLC : $658.2K total payments, HHI 374
- Janssen Research & Development, LLC : $4.7M total payments, HHI 372
- Regeneron Pharmaceuticals, Inc. : $9.1M total payments, HHI 371
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Carl Zeiss Meditec, Inc.'s, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Carl Zeiss Meditec, Inc..
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Carl Zeiss Meditec, Inc..
Showing 6 of 1,924 companies with CMS-reported payment data.
NS Pharma, Inc.
$942.1K 369 recipients
Compare payment profiles
Leica Microsystems Inc.
$942.6K 487 recipients
Compare payment profiles
Vascular Technology, Inc.
$943.2K 50 recipients
Compare payment profiles
OrganOx Ltd
$944.6K 100 recipients
Compare payment profiles
Heron Therapeutics, Inc.
$945.0K 4,695 recipients
Compare payment profiles
Put this to use
Carl Zeiss Meditec, Inc. ranks #635 of 1,925 by all-tracks total payments, led by "Consulting Fee".
- See where Carl Zeiss Meditec, Inc. sits among every top spender on the full leaderboard. Top 100 by total payments
- Compare "Consulting Fee" spend across every manufacturer, not just Carl Zeiss Meditec, Inc.. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.